Skip to Main Content

An official website of the United States government

About this Publication
Title
SNP interaction pattern identifier (SIPI): an intensive search for SNP-SNP interaction patterns.
Pubmed ID
28039167 (View this publication on the PubMed website)
Publication
Bioinformatics. 2017; Volume 33 (Issue 6): Pages 822-833
Authors
Lin HY, Chen DT, Huang PY, Liu YH, Ochoa A, Zabaleta J, Mercante DE, Fang Z, Sellers TA, Pow-Sang JM, Cheng CH, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, ...show more Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Hamdy F, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Kaneva R, Batra J, Teixeira MR, Pandha H, Lu YJ, PRACTICAL Consortium, Park JY
Affiliations
  • Biostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, USA.
  • Department of Biostatistics and Bioinformatics, Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
  • Computational Intelligence Technology Center, Industrial Technology Research Institute, Hsinchu City, Taiwan.
  • Department of Biometrics, INC Research, LLC, Raleigh, NC, USA.
  • Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, USA.
  • Department of Cancer Epidemiology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
  • Department of Genitourinary Oncology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
  • The Institute of Cancer Research, London, UK.
  • Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
  • University of Warwick, Coventry, UK.
...show more
  • Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
  • Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Department of Medical Biochemistry and Genetics, Institute of Biomedicine, University of Turku, Turku, Finland.
  • Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Cancer Epidemiology, Nuffield Department of Population Health University of Oxford, Oxford, UK.
  • Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
  • Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
  • Cambridge Institute of Public Health, University of Cambridge, Cambridge, UK.
  • Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • International Epidemiology Institute, Rockville, MD, USA.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Institute of Human Genetics University Hospital Ulm, Ulm, Germany.
  • Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA.
  • International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Molecular Medicine Center and Department of Medical Chemistry and Biochemistry, Medical University - Sofia, Sofia, Bulgaria.
  • Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and Schools of Life Science and Public Health, Queensland University of Technology, Brisbane, Australia.
  • Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
  • The University of Surrey, Guildford, Surrey, UK.
  • Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, London, UK.
Abstract

MOTIVATION: Testing SNP-SNP interactions is considered as a key for overcoming bottlenecks of genetic association studies. However, related statistical methods for testing SNP-SNP interactions are underdeveloped.

RESULTS: We propose the SNP Interaction Pattern Identifier (SIPI), which tests 45 biologically meaningful interaction patterns for a binary outcome. SIPI takes non-hierarchical models, inheritance modes and mode coding direction into consideration. The simulation results show that SIPI has higher power than MDR (Multifactor Dimensionality Reduction), AA_Full, Geno_Full (full interaction model with additive or genotypic mode) and SNPassoc in detecting interactions. Applying SIPI to the prostate cancer PRACTICAL consortium data with approximately 21 000 patients, the four SNP pairs in EGFR-EGFR , EGFR-MMP16 and EGFR-CSF1 were found to be associated with prostate cancer aggressiveness with the exact or similar pattern in the discovery and validation sets. A similar match for external validation of SNP-SNP interaction studies is suggested. We demonstrated that SIPI not only searches for more meaningful interaction patterns but can also overcome the unstable nature of interaction patterns.

AVAILABILITY AND IMPLEMENTATION: The SIPI software is freely available at http://publichealth.lsuhsc.edu/LinSoftware/ .

CONTACT: hlin1@lsuhsc.edu.

SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Related CDAS Studies
Related CDAS Projects